Revvity stock rallies 5.30% and outperforms competitors
Updated
Updated · MarketWatch · Apr 30
Revvity stock rallies 5.30% and outperforms competitors
9 articles · Updated · MarketWatch · Apr 30
Shares closed at $86.62 on Thursday, snapping a two-day losing streak as the S&P 500 rose 1.02% and the Dow gained 1.62%.
Revvity beat peers including Danaher, up 0.08%, IDEXX Laboratories, up 1.29%, and Agilent Technologies, up 3.82%, during the broad market advance.
Despite the gain, the stock remains 26.78% below its 52-week high of $118.30 reached on 22 January, while trading volume of 987,563 stayed below its 50-day average.
Revvity’s stock surged 5% after hitting a yearly low. Is this a genuine recovery or a classic bull trap for investors?
Down 27% from its high, can Revvity's niche strategy win the life sciences AI race against its giant, well-funded competitors?